| RS398124513 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked |
| RS398124520 |
ARX
|
Health Risk |
Pathogenic |
— |
| RS398124523 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS398124524 |
FLCN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS398124525 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS398124526 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Familial spontaneous pneumothorax |
| RS398124527 |
FLCN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS398124528 |
FLCN
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS398124529 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, FLCN-related disorder |
| RS398124530 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS398124531 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS398124532 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS398124533 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS398124534 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS398124535 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS398124536 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS398124538 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS398124539 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS398124540 |
FLCN
|
Health Risk |
Pathogenic |
— |
| RS398124541 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS398124542 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS398124543 |
LPIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myoglobinuria, acute recurrent |
| RS398124544 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS398124545 |
HGSNAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS398124546 |
NPHP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome and related disorders, Nephronophthisis |
| RS398124549 |
PANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS398124552 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS398124554 |
ATP2A1
|
Health Risk |
Pathogenic |
— |
| RS398124555 |
ATP2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS398124560 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease type 1B, Maple syrup urine disease |
| RS398124561 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124562 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124565 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS398124571 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124572 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398124573 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398124574 |
BCKDHB
|
Health Risk |
Pathogenic |
— |
| RS398124575 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398124576 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS398124577 |
BCKDHB
|
Health Risk |
Pathogenic |
— |
| RS398124579 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124580 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124581 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease type 1B, Maple syrup urine disease type 1A |
| RS398124582 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124585 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS398124586 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124587 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124589 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398124592 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS398124593 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124594 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124595 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124596 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398124598 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124599 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS398124600 |
BCKDHB
|
Health Risk |
Likely pathogenic |
— |
| RS398124601 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease type 1B, Maple syrup urine disease |
| RS398124602 |
BCKDHB
|
Health Risk |
Pathogenic |
— |
| RS398124603 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS398124604 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS398124607 |
NHS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nance-Horan syndrome, Inborn genetic diseases |
| RS398124608 |
NHS
|
Health Risk |
Pathogenic |
— |
| RS398124609 |
NHS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS398124610 |
NHS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Nance-Horan syndrome |
| RS398124611 |
NHS
|
Health Risk |
Pathogenic |
— |
| RS398124613 |
KIF7
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS398124615 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Macular dystrophy, Autosomal recessive bestrophinopathy |
| RS398124616 |
PORCN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398124617 |
PORCN
|
Health Risk |
Pathogenic |
— |
| RS398124618 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinal dystrophy |
| RS398124619 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS398124620 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Usher syndrome |
| RS398124621 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS398124622 |
TSEN54
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 4, Pontocerebellar hypoplasia type 4 |
| RS398124624 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS398124625 |
ANO5
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS398124626 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Miyoshi muscular dystrophy 3 |
| RS398124627 |
GATA1
|
Health Risk |
Pathogenic |
LEUKEMIA, MEGAKARYOBLASTIC |
| RS398124628 |
GATA1
|
Health Risk |
Pathogenic |
Acute megakaryoblastic leukemia, GATA binding protein 1 related thrombocytopenia with dyserythropoiesis |
| RS398124629 |
APOH
|
Health Risk |
Likely pathogenic |
— |
| RS398124631 |
POU4F3
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 15, Autosomal dominant nonsyndromic hearing loss 15 |
| RS398124632 |
BCHE
|
Health Risk |
Pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS398124633 |
FTL
|
Health Risk |
Pathogenic |
Hereditary hyperferritinemia with congenital cataracts, Neuroferritinopathy |
| RS398124634 |
FTL
|
Health Risk |
Pathogenic |
Hereditary hyperferritinemia with congenital cataracts, Hereditary hyperferritinemia with congenital cataracts |
| RS398124635 |
FTL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary hyperferritinemia with congenital cataracts, Neuroferritinopathy |
| RS398124636 |
FTL
|
Health Risk |
Pathogenic |
Hereditary hyperferritinemia with congenital cataracts, Neuroferritinopathy |
| RS398124637 |
FTL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary hyperferritinemia with congenital cataracts, Neuroferritinopathy |
| RS398124638 |
FTL
|
Health Risk |
Likely pathogenic |
Hereditary hyperferritinemia with congenital cataracts, L-ferritin deficiency |
| RS398124639 |
FTL
|
Health Risk |
Pathogenic |
Hereditary hyperferritinemia with congenital cataracts, Hereditary hyperferritinemia with congenital cataracts |
| RS398124640 |
FTL
|
Health Risk |
Likely pathogenic |
Neuroferritinopathy, Hereditary hyperferritinemia with congenital cataracts |
| RS398124641 |
SLC52A2
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 2, Inborn genetic diseases |
| RS398124642 |
SFXN4
|
Health Risk |
Pathogenic |
Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome, Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome |
| RS398124645 |
TAF2
|
Health Risk |
Pathogenic |
Microcephaly-thin corpus callosum-intellectual disability syndrome, Microcephaly-thin corpus callosum-intellectual disability syndrome |
| RS398124647 |
CALM2
|
Health Risk |
Pathogenic |
Long QT syndrome 1, Long QT syndrome 15 |
| RS398124648 |
CALM2
|
Health Risk |
Pathogenic |
Long QT syndrome 15, Long QT syndrome 1 |
| RS398124649 |
CALM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome 15, Long QT syndrome 1 |
| RS398124650 |
CALM2
|
Health Risk |
Likely pathogenic |
Long QT syndrome 15, Long QT syndrome 1 |
| RS398124651 |
FLRT3
|
Health Risk |
risk factor |
HYPOGONADOTROPIC HYPOGONADISM 21 WITH ANOSMIA, SUSCEPTIBILITY TO |
| RS398124652 |
FLRT3
|
Health Risk |
risk factor |
HYPOGONADOTROPIC HYPOGONADISM 21 WITH ANOSMIA, SUSCEPTIBILITY TO |
| RS398124653 |
FLRT3
|
Health Risk |
risk factor |
HYPOGONADOTROPIC HYPOGONADISM 21 WITH ANOSMIA, SUSCEPTIBILITY TO |